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i:10.1016/j.ijsu.2006.06.024Clomiphene citrate is a synthetic estrogen analog, which
exerts some estrogenic, but predominantly anti-estrogenic
effects. Although it has been widely used for more than 40
years for the treatment of anovulatory infertility, not much
is known about its influence on lipid metabolism. Similar to
estrogen and tamoxifen, it probably increases the level of
triglycerides in patients with baseline hypertriglyceridemia.1
Severe hypertriglyceridemia might lead to a potentially
lethal complication such as acute pancreatitis. Therefore,
awareness of this condition is of utmost importance. Herein
we present such a case, followed by a review of the
literature.
Patient description
A 27-year-old woman was admitted with diffuse abdominal
pain, fever, nausea, and vomiting of one day duration.2 8 9779222/3; fax: þ972 8
th.gov.il (A. Halevy).
6 Surgical Associates Ltd. PublishPositive findings on physical examination included obesity,
hirsutism, and a diffusely tender abdomen without perito-
neal signs. Abnormal laboratory tests consisted of lipase 550
(normal< 60 U/L), triglycerides 1845 (normal< 150 mg/dl)
and WBC 18,400 (normal< 11,000 K/mcl). She was diag-
nosed as suffering from acute pancreatitis, most probably
due to hyperlipidemia, since abdominal sonography re-
vealed an acalculous gallbladder, and alcoholismwas denied
per anamnesis.
Past medical history included gout treated by allopurinol
and colchicine, mild hypertriglyceridemia (past values of
316 and 450 mg/dl) treated occasionally by a fibrate (SR;
Hennig, Medison Pharma), and diabetes mellitus type II
treated by a low glucose diet. As a result of failure to con-
ceive, clomiphene citrate was prescribed about 6 months
prior to her admission. The dose was increased gradually
from 50 mg to 150 mg for 5 consecutive days a week ending
15 days prior to her admission.
She was discharged after 5 days with instructions not to
use similar infertility drugs thereafter and to resume
treatment with a fibrate and a low-fat diet.ed by Elsevier Ltd. All rights reserved.
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recurrent pancreatitis. Anamnesis revealed non-compliance
with the fibrate treatment and resumption of the clomi-
phene citrate treatment, ending 10 days prior to admission.
A triglyceride level of 6800 mg/dl was recorded and treat-
ment with a fibrate was reinitiated. She was discharged
4 days later and had no recurrences during an 8-month
follow-up period.
Comment
Hyperlipidemia constitutes one of the major causes of
acute pancreatitis. The mechanism probably involves the
release of large amounts of toxic fatty acids by pancreatic
lipase that damages the endothelium in the capillaries of
the pancreas. This results in sludging of red blood cells,
stasis, pancreatic ischemic injury and eventually inflamma-
tion. In addition, physical damage by cholesterol crystals
might cause microvascular endothelial cell disruption.2
It has been reported that severe drug-induced triglyc-
eride levels> 1000 mg/dl are more common in patients
with underlying familial hypertriglyceridemia.3,4 Exogenous
factors which raise triglyceride levels include exogenous
estrogens, corticosteroids, beta-blockers, diuretics, selec-
tive estrogen receptor modulators, clomiphene, isotretinoin,
protease inhibitors, hyperestrogenemia of pregnancy,
poorly controlled diabetes mellitus, hypothyroidism, multi-
ple myeloma, systemic lupus erythematosus, lymphoma
and alcohol excess.5
Exogenous estrogens elevate triglycerides by increasing
the production of triglyceride-carrying very low density
lipoproteins (VLDLs) by the liver and reducing the levels of
lipoprotein lipase (LPL) and hepatic lipase, thus reducing
triglyceride clearance, while also elevating triglycerides by
augmentation of insulin resistance.3,5
Tamoxifen is known to cause a small, but significant
decrease in high-density lipoprotein (HDL) cholesterol,
unlike estrogen, which elevates HDL. In women with
hypertriglyceridemia, tamoxifen’s ability to increase the
triglyceride level is especially pronounced, to an extent
that may induce acute pancreatitis.3,4
Clomiphene citrate is a synthetic estrogen analog with
a biochemical structure similar to that of tamoxifen.Clomiphene has mixed agonistic, but mainly antagonistic
properties.1
We presume that the effects of clomiphene on lipid
metabolism have not been as well-documented as the
effects of tamoxifen because it is not used continuously
and not as commonly as tamoxifen. Clomiphene elevates
the triglyceride level mainly in women with a predisposed
risk for hypertriglyceridemia, due to mutations in enzymes
such as LPL.
To the best of our knowledge, this is the second report
on clomiphene citrate-induced hypertriglyceridemic acute
pancreatitis.1
In conclusion, clomiphene citrate is one of the most
common drugs used to treat infertility. Given the structural
similarity between clomiphene citrate and tamoxifen, it is
likely that it is capable of causing severe hypertriglycer-
idemia in a manner similar to that of tamoxifen, which can
eventually induce pancreatitis.
We suggest that prior to commencing treatment with
clomiphene citrate, the triglyceride level should be
measured, in order to avoid hypertriglyceridemic acute
pancreatitis and exacerbation of overt or covert familial
hypertriglyceridemia. In women with preexisting hyper-
triglyceridemia (triglycerides 500 mg/dl), clomiphene
citrate should be avoided.
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